Black Diamond Therapeutics, Inc.
Black Diamond Therapeutics, Inc.（BDTX）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · BDTX · 截至 2026年6月9日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
0
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Black Diamond Therapeutics, Inc.内部人在过去近12个月买卖活动混合。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
BDTX 季度内部人买卖趋势
BDTX 内幕交易卖出 · BDTX 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · BDTX CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
BDTX 高管卖出股份 · BDTX 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Mar 20, 2026 | Behbahani Ali Director | Award | 6,919 | $15K | Form 4 |
| Mar 20, 2026 | Raman Prakash Director | Award | 6,105 | $13K | Form 4 |
| Dec 12, 2025 | Behbahani Ali Director | Award | 5,208 | $14K | Form 4 |
| Dec 12, 2025 | Raman Prakash Director | Award | 4,665 | $13K | Form 4 |
| Sep 19, 2025 | Behbahani Ali Director | Award | 4,291 | $14K | Form 4 |
| Sep 19, 2025 | Raman Prakash Director | Award | 3,843 | $13K | Form 4 |
| Jun 20, 2025 | Behbahani Ali Director | Award | 6,170 | $14K | Form 4 |
| Jun 20, 2025 | Raman Prakash Director | Award | 5,526 | $13K | Form 4 |
| Mar 21, 2025 | Behbahani Ali Director | Award | 7,646 | $14K | Form 4 |
| Mar 21, 2025 | Raman Prakash Director | Award | 6,848 | $13K | Form 4 |
| Mar 19, 2025 | BIOTECH GROWTH N V 10 percent owner | Sale | 1,000,000 | $2.07M⚡ | Form 4 |
| Mar 19, 2025 | BIOTECH GROWTH N V 10 percent owner | Sale | 300,000 | $583K | Form 4 |
| Mar 19, 2025 | BIOTECH GROWTH N V 10 percent owner | Sale | 1,000,000 | $2.31M⚡ | Form 4 |
| Mar 19, 2025 | BIOTECH GROWTH N V 10 percent owner | Sale | 2,000,000 | $4.00M⚡ | Form 4 |
| Mar 19, 2025 | BIOTECH GROWTH N V 10 percent owner | Sale | 400,000 | $837K | Form 4 |
| Mar 19, 2025 | BIOTECH GROWTH N V 10 percent owner | Sale | 584,292 | $1.14M⚡ | Form 4 |
| Mar 19, 2025 | BIOTECH GROWTH N V 10 percent owner | Sale | 500,000 | $1.06M⚡ | Form 4 |
| Jan 30, 2025 | Velleca Mark A. PRESIDENT & CEO · Director | Award | 75,000 | — | Form 4 |
| Jan 30, 2025 | Yurasov Sergey CHIEF MEDICAL OFFICER | Award | 75,000 | — | Form 4 |
| Jan 30, 2025 | Buck Elizabeth CHIEF SCIENTIFIC OFFICER | Award | 75,000 | — | Form 4 |
| Jan 30, 2025 | Jones Erika SEE REMARKS | Award | 75,000 | — | Form 4 |
| Jan 30, 2025 | Hatzis-Schoch Brent SEE REMARKS | Award | 75,000 | — | Form 4 |
| Dec 13, 2024 | Behbahani Ali Director | Award | 5,750 | $14K | Form 4 |
| Dec 13, 2024 | Raman Prakash Director | Award | 5,150 | $13K | Form 4 |
| Dec 13, 2024 | Campbell Shannon Director | Award | 4,500 | $11K | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 BDTX 内幕交易
BDTX 内幕交易
Black Diamond Therapeutics, Inc.（BDTX）内幕交易数据来源于公司内部人（包括Behbahani Ali (Director), Raman Prakash (Director)）提交的SEC Form 4申报文件。过去12个月内，2位内部人向SEC提交了交易申报。BDTX内部人近期买卖活动混合，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Black Diamond Therapeutics, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
BDTX 内幕交易 · 5个问题Black Diamond Therapeutics, Inc.（BDTX）的内部人包括高管和董事，如Behbahani Ali (Director), Raman Prakash (Director)等。过去12个月内，2位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026